Biorepository Clinical trials

Hightower Clinical is conducting biorepository clinical trials in Oklahoma City, OK, to monitor and profile longitudinal ctDNA biomarkers in cancer patients. This non-interventional, multicenter study aims to track biomarker changes over time, helping improve cancer diagnosis and monitoring. Patients will undergo routine plasma ctDNA biomarker tests at specific intervals while receiving standard care therapy. The goal is to advance understanding of how ctDNA biomarkers evolve throughout treatment, offering insights into patient outcomes.

Join our head and neck cancer biorepository clinical trials in Oklahoma City, OK, and help advance research that could improve treatments and outcomes for patients with head and neck squamous cell carcinoma (HNSCC). These trials focus on collecting tissue and blood samples during standard treatment to analyze molecular biomarkers, aiming to improve therapeutic options. Participants receive all study-related care at no cost, with no insurance required. To take part, simply fill out the form, and a member of our research team will contact you to assess your eligibility.

At Hightower Clinical, one of our studies aims to examine how different types of videos about colorectal cancer (CRC) screening influence screening rates and adherence to guidelines over time. Participants aged 45 to 70, due for a colonoscopy or other CRC screening, will be randomly assigned to one of three groups.

Additionally, blood and tissue samples will be collected to study biomarkers—key indicators that may help predict cancer risk or detect cancer earlier. This research could lead to improved cancer screening tests in the future.